- Home
- / Shanghai Junshi Biosciences
- / Financials
Shanghai Junshi BiosciencesHeader placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Financial statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
| Revenue | 684.0K | 766.8M | 1.5B | 3.8B |
| Cost of goods sold | (2.0M) | (90.7M) | (372.5M) | (1.2B) |
| Gross profit | (1.3M) | 677.1M | 1.2B | 2.8B |
| Operating expense total | (657.9M) | (1.4B) | (2.8B) | (3.2B) |
| Depreciation and amortization | (33.4M) | (44.3M) | (132.3M) | (218.7M) |
| EBITDA | (659.2M) | (761.7M) | (1.6B) | (453.3M) |
| EBIT | (682.5M) | (778.0M) | (1.6B) | (516.4M) |
| Interest income | 3.8M | 29.2M | 20.3M | 31.0M |
| Interest expense | (4.1M) | (13.3M) | (29.4M) | (21.8M) |
| Pre tax profit | (724.1M) | (766.6M) | (1.7B) | (595.0M) |
| Income tax expense | 1.2M | 18.9M | 3.8M | (135.5M) |
| Net Income | (722.9M) | (747.7M) | (1.7B) | (730.5M) |